We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byBrandon Riley
Modified over 2 years ago
© 2010, American Heart Association. All rights reserved. Evolving Patterns of Use and Appropriateness of Aldosterone Antagonists in Heart Failure Nancy M. Albert, PhD, RN; Clyde W. Yancy, MD; Li Liang, PhD; Adrian F. Hernandez, MD; Eric D. Peterson, MD, MPH, Xin Zhao, MS, Christopher P. Cannon, MD; Gregg C. Fonarow, MD Albert et al. JAMA. 2009;302(15):
© 2010, American Heart Association. All rights reserved. Background Aldosterone antagonists are recommended in patients with moderate-to-severe heart failure (HF) and systolic dysfunction. Prior studies suggest underutilization of aldosterone antagonists in eligible patients as well as overuse in settings where therapy may be harmful. Albert et al. JAMA. 2009;302(15):
© 2010, American Heart Association. All rights reserved. Introduction Data support the use of aldosterone antagonists in heart failure patients. Aldosterone antagonists are underutilized in eligible patients. The GWTG Program has been shown to improve the appropriate use of aldosterone antagonist therapy in heart failure patients. Albert et al. JAMA. 2009;302(15):
© 2010, American Heart Association. All rights reserved. Objective The purpose of the paper was to evaluate whether a hospital-based quality program such as GWTG improves the use of aldosterone antagonist therapy in the appropriate patient population. Albert et al. JAMA. 2009;302(15):
© 2010, American Heart Association. All rights reserved. Methods Observational analysisObservational analysis Outcome measures were prescription and predictors of use of aldosterone antagonists, based on guideline criteria.Outcome measures were prescription and predictors of use of aldosterone antagonists, based on guideline criteria. 43,625 patients admitted with HF and discharged home from 241 hospitals participating in the Get With The Guidelines--HF quality improvement registry between ,625 patients admitted with HF and discharged home from 241 hospitals participating in the Get With The Guidelines--HF quality improvement registry between Albert et al. JAMA. 2009;302(15):
© 2010, American Heart Association. All rights reserved. Results Rates of inappropriate use of aldosterone antagonists are low: 0.5% use in patients with documented contraindications and 2.7% use in patients with higher than recommended creatine levels. The data suggest that less than one third of eligible HF patients were prescribed an aldosterone antagonist. Only 32.5% (4,087 out of 12,565) of eligible HF patients were prescribed aldosterone antagonist therapy at discharge. Over the study period, the number of eligible HF patients receiving an aldosterone antagonist increased from 28% to 34%. The data showed that the following patient populations received aldosterone antagonist at a higher rate: young patients, African Americans, those with lower systolic blood pressures, a history of implantable cardioverter-defibrillator use, depression, alcohol use, and pacemaker implantation, and those with no history of renal insufficiency. Increases in aldosterone antagonist usage in eligible patients were small from and stayed below 35% while inappropriate aldosterone antagonist use remained low. Albert et al. JAMA. 2009;302(15): Albert JAMA 2009
© 2010, American Heart Association. All rights reserved. Conclusions These data suggest that in the context of a hospital- based performance improvement program, aldosterone antagonist therapy can be used according to guidelines with little inappropriate use. Given the substantial morbidity and mortality risk faced by patients hospitalized with HF and the established efficacy of aldosterone antagonist use in HF, a stronger uptake of aldosterone antagonist therapy indicated by evidence-based guidelines may be warranted. Albert et al. JAMA. 2009;302(15):
© 2010, American Heart Association. All rights reserved. A Validated Risk Score for In-hospital Mortality in Patients with Heart Failure from the American.
© 2010, American Heart Association. All rights reserved. Are Quality Improvements Associated with the GWTG-Coronary Artery Disease (GWTG-CAD) Program Sustained.
© 2010, American Heart Association. All rights Association of Hospital Primary Angioplasty Volume in ST-Segment Elevation Myocardial Infarction With Quality.
Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of the Registry to Improve Heart Failure Therapies.
© 2010, American Heart Association. All rights reserved. Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute.
Associations Between Outpatient Heart Failure Process of Care Measures and Mortality Gregg C. Fonarow, Nancy M. Albert, Anne B. Curtis, Mihai Gheorghiade,
Ovbiagele et al. Epub May 27, Stroke. Recent Nationwide Trends in Discharge Statin Treatment of Hospitalized Patients with Stroke Bruce Ovbiagele,
J essup et al (2009) Circulation © 2009, American Heart Association. All rights reserved Focused Update: ACC/AHA Guidelines for the Diagnosis and.
Saver et al. Epub June 3, 2010 STROKE The Golden Hour and Acute Brain Ischemia: Presenting Features and Lytic Therapy in Over 30,000 Patients Arriving.
0 Based on the 2009 Focused Update Incorporated Into the ACCF/AHA 2005 guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report.
Journal Club Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital 9/12/2010 Nir Hus MD., PhD. Ryder Trauma Center Jackson Memorial Hospital.
Incremental Reduction in Risk of Death Associated with Use of Guideline- Recommended Therapies in Patients with Heart Failure: A Nested Case Control Analysis.
POSTER TEMPLATE BY: University of North Carolina Wilmington A Novel Collaborative Practice Model (CPM) for the Treatment of.
Quality of Care for Stroke Patients Jerilyn Alexander, RN Stroke Coordinator Trinity Health.
1 Evolving Issues in Colonoscopy May 19, 2011 This 3rd part of the lectures today will be presented by: Stanley H. Weiss, MD, FACP, FACE – Professor, Preventive.
An audit of the antithrombotic therapy for the management of valve repair or replacement Gellatly RM 1,2, Maydelmin D 1, Connell C 1, Marasco S 3, Zimmet.
2/14/2014© 2009, American Heart Association. All rights reserved.
Evidence guiding health care. Source Kapral MK, Hall RE, Silver FL, Robertson AC, Fang J. Registry of the Canadian Stroke Network. Report on the 2004/05.
A Guideline for Healthcare Professionals From the American Heart Association & American Stroke Association Metrics for Measuring Quality of Care in Comprehensive.
THE IMPORTANCE OF FEEDBACK TO ENHANCE THE IMPACT OF EFFECTIVE INTERVENTIONS TO REDUCE ANTIBIOTICS IN ACUTE RESPIRATORY- TRACT INFECTION Yudatiningsih I.
1. 2 PROGRAM FACULTY This program and enduring materials are aligned with Consensus Guidelines and have been developed by the Program Faculty with input.
Integrating the care of NCD into PHC ECOSOC/UNESCWA/WHO Doha, May 10 th 2009 Nabil M Kronfol MD, DrPH.
Utilizing the Electronic Medical Record to Reduce Inappropriate Medication Use Alan White, PhD – Abt Associates Valerie Weber, MD – Geisinger Health System.
1 Pacemaker Patient Follow-up Module 8. 2 Objectives List the steps for performing a pacemaker follow-up Locate threshold, sensing and impedance data.
Achieving Equality in Health and Social Care for Older People: Opportunities and Challenges Nat Lievesley Centre for Policy on Ageing December 2013 Evidence.
0 ESC Gudelines 2008 ESC Guidelines Heart failure update 2008 ESC Guidelines Update 2008 European Heart Journal, doi: /eurheart/ehn309 European.
2013 ACCF/AHA Guideline for the Management of Heart Failure Developed in Collaboration With the American Academy of Family Physicians, American College.
AHA/ASA Scientific Statement Race-Ethnic Disparities in Stroke Care: The American Experience 0.
Meeting the psychological needs of cardiac patients – an integrated stepped- care approach within a Cardiac Rehabilitation setting Professor Myra Hunter.
Mohanad Shukry, MD Associate Professor in Anesthesiology Director, Pediatric Pain Management Service The Children’s Hospital 1.
© 2016 SlidePlayer.com Inc. All rights reserved.